Page last updated: 2024-09-03

olmesartan medoxomil and Albuminuria

olmesartan medoxomil has been researched along with Albuminuria in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, TX; Ding, A; Li, ZL; Yang, H; Zhang, H; Zhang, HT; Zhu, WP; Zhu, Y1
Chin, HJ; Choi, BS; Kim, DK; Lee, SH; Lim, CS; Park, JH; Shin, SJ; Yu, MY1
Chatzikyrkou, C; Haller, H; Menne, J; Ritz, E; Ruilope, LM; Viberti, G1
Kaul, U; Mansoor, A; Sabbah, ZA1
An, JN; Chin, HJ; Choi, BS; Hwang, JH; Kim, DK; Kim, S; Lee, JP; Lee, SH; Lim, CS; Park, JH; Shin, SJ1
Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Yoshida, K; Yoshiyama, M1

Trials

3 trial(s) available for olmesartan medoxomil and Albuminuria

ArticleYear
Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.
    PloS one, 2018, Volume: 13, Issue:8

    Topics: Aged; Albuminuria; Angiotensin II Type 2 Receptor Blockers; Area Under Curve; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Olmesartan Medoxomil; Renal Insufficiency, Chronic; Risk Factors; ROC Curve

2018
The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.
    Journal of the American Heart Association, 2014, Volume: 3, Issue:2

    Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Imidazoles; Kidney; Logistic Models; Male; Middle Aged; Odds Ratio; Olmesartan Medoxomil; Proportional Hazards Models; Renin-Angiotensin System; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome

2014
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Albuminuria; Angiotensin Receptor Antagonists; Case-Control Studies; Erythropoietin; Female; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Receptors, Angiotensin; Renin-Angiotensin System; Treatment Outcome

2015

Other Studies

3 other study(ies) available for olmesartan medoxomil and Albuminuria

ArticleYear
Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Male; Mice; Olmesartan Medoxomil

2019
Angiotensin receptor blockers - advantages of the new sartans.
    The Journal of the Association of Physicians of India, 2013, Volume: 61, Issue:7

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Telmisartan; Tetrazoles; Treatment Outcome

2013
Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:10

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiac Output, Low; Creatinine; Dihydropyridines; Drug Combinations; Echocardiography; Gene Expression; Hypertension; Imidazoles; Myocardium; Olmesartan Medoxomil; Organ Size; Rats; Rats, Inbred Dahl; Survival Analysis; Tetrazoles; Thiazepines

2004